Skip to main content
. 2020 Oct 1;160(1):88–98.e4. doi: 10.1053/j.gastro.2020.09.041

Table 1.

Survey-Weighted Baseline Patient Demographic Characteristics From Sampled Ambulatory Visits for Chronic, Symptomatic FBDs in the NAMCS, 2007–2015

Characteristics All Chronic Functional Bowel Disorders (95% CI) IBS or Chronic Abdominal Pain (95% CI) Chronic Constipation (95% CI) Chronic Diarrhea (95% CI)
Weighted sample visits, N 36,938,000 (31,452,000–42,424,000) 24,381,000 (20,304,000–28,458,000) 8,930,000 (6,809,000–10,948,000) 6,197,000 (4,824,000–7,570,000)
Average annual weighted visits, N 4,104,000 (3,495,000–4,714,000) 2,730,000 (2,273,000–3,187,000) 992,000 (768,000–1,216,000) 689,000 (536,000–841,000)
Age, y, %
 18–39 18.3 (15.6–21.4) 21.0 (17.3–25.3) 17.9 (12.7–24.6) 17.7 (11.6–25.9)
 40–59 35.5 (31.1–40.1) 37.2 (31.7–43.1) 26.6 (19.8–34.8) 39.7 (30.4–49.8)
 60–79 35.6 (30.8–40.7) 34.7 (28.4–41.5) 40.4 (32.4–49.0) 28.7 (21.4–37.3)
 ≥80 10.6 (8.0–14.0) 7.2 (4.6–11.0) 15.1 (10.0–22.1) a
Female sex, % 66.8 (62.1–71.1) 66.9 (60.6–72.7) 70.0 (61.6–77.2) 64.5 (54.7–73.2)
Race, %
 White 84.4 (79.2–88.4) 83.2 (76.3–88.4) 85.5 (78.7–90.4) 90.7 (83.0–95.1)
 Black 9.8 (7.3–13.1) 9.6 (6.7–13.4) 11.0 (6.8–17.2) a
 Other 5.7 (3.0–10.2) a a a
Current tobacco use, % 15.0 (12.0–18.7) 14.5 (10.8–19.2) 12.8 (7.7–20.4) 22.2 (14.3–32.8)
Primary payment method, %
 Private insurance 52.0 (46.4–57.4) 57.4 (51.1–63.4) 44.5 (36.1–53.3) 47.7 (37.8–57.7)
 Medicare/Medicaid 44.7 (39.5–49.9) 39.7 (34.0–45.8) 53.6 (44.9–62.1) 44.3 (35.4–53.6)
 Other 3.3 (2.2–4.8) 2.9 (1.9–4.5) a a
US region, %
 Northeast 18.3 (13.7–24) 20.1 (14.7–26.8) 14.0 (8.7–21.8) 14.8 (8.5–24.7)
 Midwest 19.0 (14.5–24.5) 17.4 (12.6–23.6) 22.8 (15.4–32.4) 19.5 (12.5–29.2)
 South 40.1 (32.7–47.9) 39.3 (31.3–47.9) 47.5 (36.4–58.9) 38.6 (28.8–49.3)
 West 22.5 (16.9–29.2) 23.2 (16.5–31.6) 15.7 (9.5–24.8) 27.1 (17.7–39.1)
Physician specialty, %
 Primary care 47.0 (39.8–54.4) 47.9 (39.5–56.4) 44.2 (33.8–55.0) 41.6 (31.3–52.7)
 Medical care 45.4 (37.5–53.5) 44.3 (35.5–53.4) 49.3 (37.9–60.8) 52.2 (41.2–63.0)
Health care visits in past year, %
 0 27.2 (22.2–32.8) 27.1 (21.8–33.2) 26.9 (18.7–37.0) 27.7 (20.1–36.9)
 1–2 33.3 (28.1 – 39.0) 36.7 (30.1–43.8) 31.9 (25.2–39.5) 23.7 (16.7–32.5)
 3–6 26.1 (22.2–30.4) 23.4 (19.2–28.2) 29.1 (21.8–37.6) 33.1 (24.6–43.0)
 ≥7 13.3 (10.1–17.4) 12.8 (8.8–18.1) 12.2 (8.0–18.1) 15.1 (8.5–26.4)
Comorbidity burden, %
 0 comorbidities 35.4 (30.8–40.1) 35.9 (30.4–41.7) 36.4 (28.5–45.2) 35.8 (27.4–45.3)
 1 comorbidity 23.8 (19.5–28.7) 25.8 (20.1–32.5) 22.7 (16.3–30.5) 20.7 (14.7–28.3)
 ≥2 comorbidities 40.7 (35.8–45.8) 38.3 (32.3–44.8) 40.9 (32.5–50.0) 43.5 (33.5 – 54.0)
Selected comorbidities, %
 Depression 14.2 (11.7–17.1) 15.5 (12.2–19.5) 12.2 (7.8–18.6) 15.8 (9.5–25.0)
 Obesity 9.4 (7.2–12.1) 9.0 (6.6–12.1) 9.9 (5.8–16.3) 12.4 (7.0 – 21.1)
 Cancer 7.5 (4.3–12.8) a a a
 Diabetes 16.2 (12.5–20.9) 13.1 (8.4 – 19.9) 16.7 (11.1–24.2) 24.7 (16.7–35.0)
a

Weighted estimate suppressed because of <30 unweighted observations or relative standard error of >30% (unreliable estimate).